{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:19:42Z","timestamp":1791235182313,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-03733-z","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T23:00:22Z","timestamp":1745190022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cervical cancer screening: a comparative study of TruScreen vs. Pap Smear"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-6969","authenticated-orcid":false,"given":"Majed","family":"Alhudhud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Maqsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maab El","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Sarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Al Khalidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Bishtawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"5","key":"3733_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J cancer. 2015;136(5):E359\u201386.","journal-title":"Int J cancer"},{"issue":"3","key":"3733_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3733_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"3733_CR4","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/jnci\/94.19.1469","volume":"94","author":"JS Mandelblatt","year":"2002","unstructured":"Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, et al. Costs and Benefits of Different Strategies to Screen for Cervical Cancer in Less-Developed Countries. JNCI J Natl Cancer Inst. 2002;94(19):1469\u201383.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"03","key":"3733_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4236\/ojog.2013.33063","volume":"03","author":"T Allameh","year":"2013","unstructured":"Allameh T, Khanjani S, Mohammadizadeh F, Refaei E. Diagnostic value of the combination of TruScreen and Pap smear in screening cervical epithelial lesions: Does it add advantages over the Pap smear alone? Open J Obstet Gynecol. 2013;03(03):341\u20136.","journal-title":"Open J Obstet Gynecol"},{"issue":"6","key":"3733_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, et al. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. N Engl J Med. 2003;348(6):518\u201327.","journal-title":"N Engl J Med"},{"issue":"12","key":"3733_CR7","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1002\/ijc.25630","volume":"128","author":"K Matsumoto","year":"2011","unstructured":"Matsumoto K, Oki A, Furuta R, Maeda H, Yasugi T, Takatsuka N, et al. Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study. Int J cancer. 2011;128(12):2898\u2013910.","journal-title":"Int J cancer"},{"issue":"3","key":"3733_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/jnci\/91.3.252","volume":"91","author":"P Holowaty","year":"1999","unstructured":"Holowaty P, Miller AB, Rohan T, To T. Natural History of Dysplasia of the Uterine Cervix. JNCI J Natl Cancer Inst. 1999;91(3):252\u20138.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"1","key":"3733_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1186\/s12885-022-10030-7","volume":"22","author":"N Dorji","year":"2022","unstructured":"Dorji N, Tshering S, Choden S, Chhetri M, Bhujel D, Wangden T, et al. Evaluation of the diagnostic performance of colposcopy in the diagnosis of histologic cervical intraepithelial neoplasia 2+ (CIN2+). BMC Cancer. 2022;22(1):930.","journal-title":"BMC Cancer"},{"key":"3733_CR10","first-page":"1454","volume":"16","author":"DC Stefan","year":"2022","unstructured":"Stefan DC, Dangou JM, Barango P, Mahamadou ID, Kapambwe S. Targeting elimination of cervical cancer by 2030: a baseline assessment in six African countries\u2014part II. Ecancermedicalscience. 2022;16:1454.","journal-title":"Ecancermedicalscience."},{"key":"3733_CR11","unstructured":"UN General Assembly, Transforming our world : the 2030 Agenda for Sustainable Development, A\/RES\/70\/1, 21 October 2015. https:\/\/www.refworld.org\/legal\/resolution\/unga\/2015\/en\/111816. Accessed 15 Apr 2025."},{"key":"3733_CR12","first-page":"1","volume":"2","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem and its associated goals and targets for the period 2020\u20132030. United Nations General Assembly. 2020;2:1\u201356.","journal-title":"United Nations General Assembly"},{"issue":"10","key":"3733_CR13","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1158\/1055-9965.EPI-07-2659","volume":"17","author":"E Lazcano-Ponce","year":"2008","unstructured":"Lazcano-Ponce E, Palacio-Mejia LS, Allen-Leigh B, Yunes-Diaz E, Alonso P, Schiavon R, et al. Decreasing Cervical Cancer Mortality in Mexico: Effect of Papanicolaou Coverage, Birthrate, and the Importance of Diagnostic Validity of Cytology. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2808\u201317.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3733_CR14","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.12659\/MSM.895227","volume":"21","author":"MU Barut","year":"2015","unstructured":"Barut MU, Kale A, Kuyumcuo\u011flu U, Bozkurt M, A\u011fa\u00e7ayak E, \u00d6zekinci S, et al. Analysis of Sensitivity, Specificity, and Positive and Negative Predictive Values of Smear and Colposcopy in Diagnosis of Premalignant and Malignant Cervical Lesions. Med Sci Monit. 2015;21:3860.","journal-title":"Med Sci Monit"},{"issue":"2","key":"3733_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1471-0528.2008.02047.x","volume":"116","author":"J Louwers","year":"2009","unstructured":"Louwers J, Kocken M, ter Harmsel W, Verheijen R. Digital colposcopy: ready for use? An overview of literature. BJOG An Int J Obstet Gynaecol. 2009;116(2):220\u20139.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"1","key":"3733_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijgo.2010.10.012","volume":"113","author":"C Sauvaget","year":"2011","unstructured":"Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankaranarayanan R. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynecol Obstet. 2011;113(1):14\u201324.","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"3733_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.sxmr.2019.09.005","volume":"8","author":"SL Bedell","year":"2020","unstructured":"Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical Cancer Screening: Past, Present, and Future. Sex Med Rev. 2020;8(1):28\u201337.","journal-title":"Sex Med Rev"},{"issue":"3","key":"3733_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4103\/JOC.JOC_111_17","volume":"35","author":"J Salazar-Campos","year":"2018","unstructured":"Salazar-Campos J, Gonz\u00e1lez-Enciso A, D\u00edaz-Molina R, Lara-Hern\u00e1ndez M, Coronel-Mart\u00ednez J, P\u00e9rez-Plasencia C, et al. Cervicouterine cancer screening \u2013 TruScreen\u2122 vs. conventional cytology: Pilot study. J Cytol. 2018;35(3):143.","journal-title":"J Cytol."},{"issue":"10","key":"3733_CR19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2217\/fon-2020-0928","volume":"17","author":"Z Wang","year":"2021","unstructured":"Wang Z, Kang Y, Yu F, Zhong FH, Huang K, Zhou X, et al. TruScreen detection of cervical tissues for high-risk human papillomavirus-infected women during the COVID-19 pandemic. Futur Oncol. 2021;17(10):1197\u2013207.","journal-title":"Futur Oncol"},{"issue":"7","key":"3733_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233986","volume":"15","author":"Y Ma","year":"2020","unstructured":"Ma Y, Di J, Bi H, Zhao Q, Qin T, Xu W, et al. Comparison of the detection rate of cervical lesion with TruScreen, LBC test and HPV test: A Real-world study based on population screening of cervical cancer in rural areas of China. PLoS ONE. 2020;15(7):e0233986.","journal-title":"PLoS ONE"},{"key":"3733_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejogrb.2021.09.027","volume":"266","author":"Y Wei","year":"2021","unstructured":"Wei Y, Wang W, Cheng M, Hong Z, Gu L, Niu J, et al. Clinical evaluation of a real-time optoelectronic device in cervical cancer screening. Eur J Obstet Gynecol Reprod Biol. 2021;266:182\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"3733_CR22","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/ijgc-00009577-200311000-00011","volume":"13","author":"A Singer","year":"2003","unstructured":"Singer A, Coppleson M, Canfell K, Skladnev V, Mackellar G, Pisal N, et al. A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: A multicenter evaluation. Int J Gynecol Cancer. 2003;13(6):804\u201311.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"3733_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1212\/WNL.0000000000000621","volume":"83","author":"AH Noel-Storr","year":"2014","unstructured":"Noel-Storr AH, McCleery JM, Richard E, Ritchie CW, Flicker L, Cullum SJ, et al. Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative. Neurology. 2014;83(4):364\u201373.","journal-title":"Neurology"},{"key":"3733_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.25259\/CMAS_03_07_2021","volume":"19","author":"MA Pangarkar","year":"2022","unstructured":"Pangarkar MA. The Bethesda System for reporting cervical cytology. Cytojournal. 2022;19:28.","journal-title":"Cytojournal"},{"key":"3733_CR25","unstructured":"Public Health England publications. Cervical screening: histopathology reporting handbook, NHS England. Gateway number: GW-1223. Updated 27 September 2024. https:\/\/www.gov.uk\/government\/publications\/cervical-screening-histopathology-reporting-handbook\/cervical-screening-programme-histopathology-reporting-guidance."},{"key":"3733_CR26","unstructured":"Australian Institute of Health and Welfare. Cervical screening in Australia 2019. Cancer series no. 123. Cat. no. CAN 124. Canberra: AIHW. https:\/\/www.aihw.gov.au\/getmedia\/6a9ffb2c-0c3b-45a1-b7b5-0c259bde634c\/aihw-can-124.pdf?v=20230605165529&inline=true."},{"key":"3733_CR27","unstructured":"World Health Organization. Comprehensive Cervical Cancer Control: A Guide to Essential Practice. 2nd ed. Geneva: WHO; 2014. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK269619\/.\u00a0PMID: 25642554."},{"key":"3733_CR28","doi-asserted-by":"crossref","unstructured":"Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004;364(9430):249\u201356. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673604166749.","DOI":"10.1016\/S0140-6736(04)16674-9"},{"issue":"5","key":"3733_CR29","doi-asserted-by":"publisher","DOI":"10.2196\/22160","volume":"7","author":"F Safaeian","year":"2021","unstructured":"Safaeian F, Ghaemimood S, El-Khatib Z, Enayati S, Mirkazemi R, Reeder B. Burden of Cervical Cancer in the Eastern Mediterranean Region During the Years 2000 and 2017: Retrospective Data Analysis of the Global Burden of Disease Study. JMIR Public Heal Surveill. 2021;7(5):e22160.","journal-title":"JMIR Public Heal Surveill"},{"issue":"11","key":"3733_CR30","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3855\/jidc.9704","volume":"11","author":"FS Alhamlan","year":"2017","unstructured":"Alhamlan FS, AlAhdal MNA, Al-Zahrani AS, Almatrrouk SA. Human papillomaviruses: The cervical cancer saga in developing countries. J Infect Dev Ctries. 2017;11(11):819\u201325.","journal-title":"J Infect Dev Ctries"},{"issue":"02","key":"3733_CR31","doi-asserted-by":"publisher","first-page":"079","DOI":"10.4103\/2278-330X.181646","volume":"05","author":"DB Nikumbh","year":"2016","unstructured":"Nikumbh DB, Nikumbh RD, Kanthikar SN. Limitations of cytological cervical cancer screening (Papanicolaou test) regarding technical and cultural aspect in rural India. South Asian J Cancer. 2016;05(02):079\u2013079.","journal-title":"South Asian J Cancer"},{"issue":"4","key":"3733_CR32","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3802\/jgo.2012.23.4.282","volume":"23","author":"JD Boone","year":"2012","unstructured":"Boone JD, Erickson BK, Huh WK. New insights into cervical cancer screening. J Gynecol Oncol. 2012;23(4):282.","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"3733_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.5144\/0256-4947.2017.265","volume":"37","author":"H Nasser","year":"2017","unstructured":"Nasser H, AlAyyaf M, Atallah A, Aminulislam M, Rizwan L, Aodah A, et al. Eleven-year review of data on Pap smears in Saudi Arabia: We need more focus on glandular abnormalities! Ann Saudi Med. 2017;37(4):265\u201371.","journal-title":"Ann Saudi Med"},{"issue":"1","key":"3733_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5152\/jtgga.2015.15199","volume":"16","author":"E Ozgu","year":"2015","unstructured":"Ozgu E, Yildiz Y, Salman Ozgu B, Oz M, Danisman N, Gungor T. Efficacy of a real time optoelectronic device (TruScreen\u2122) in detecting cervical intraepithelial pathologies: a prospective observational study. J Turkish Ger Gynecol Assoc. 2015;16(1):41\u20134.","journal-title":"J Turkish Ger Gynecol Assoc"},{"issue":"29","key":"3733_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011439","volume":"97","author":"H Yang","year":"2018","unstructured":"Yang H, Zhang X, Hao Z. The diagnostic accuracy of a real-time optoelectronic device in cervical cancer screening. Medicine (Baltimore). 2018;97(29):e11439.","journal-title":"Medicine (Baltimore)"},{"key":"3733_CR36","doi-asserted-by":"crossref","unstructured":"Pruski D, Przybylski M, K\u0119dzia W, K\u0119dzia H, Jagielska-Pruska J, Spaczy\u0144ski M. Optoelectronic method for detection of cervical intraepithelial neoplasia and cervical cancer. Opto-Electronics Rev. 2011;19(4). Available from: http:\/\/www.degruyter.com\/view\/j\/oere.2011.19.issue-4\/s11772-011-0040-4\/s11772-011-0040-4.xml.","DOI":"10.2478\/s11772-011-0040-4"},{"key":"3733_CR37","unstructured":"Pruski D, Kedzia W, Przybylski M, J\u00f3zefiak A, Purol M, Spaczy\u0144ski M. [Assessment of optoelectronic method and molecular test usefulness for cervical intraepithelial neoplasia and cervical cancer detection]. Ginekol Pol. 2010;81(6):426\u201330. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20695191."},{"key":"3733_CR38","unstructured":"Pruski D, Kedzia W, Przybylski M, J\u00f3zefiak A, Kedzia H, Spaczy\u0144ski M. [Assesment of real optoelectronic method in the detection of cervical intraepithelial neoplasia]. Ginekol Pol. 2008 May;79(5):342\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18624109."}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03733-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03733-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03733-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T23:00:27Z","timestamp":1745190027000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03733-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3733"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03733-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4638793\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of the institutional review board (IRB) (Ref No. Dr. Sulaiman Al-Habib Medical Group \u2013 RC20.08.91- Aug 2020).All patients were required to sign the informed consent before enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}